Home Compare ABBV vs ROG.SW
Stock Comparison · Industry comparison · Drug Manufacturers - General

AbbVie vs Roche Holding: Which Stock Looks Stronger in 2026?

Roche holds the cleaner structural position, with the lead spread across profitability and valuation. AbbVie does not offset that deficit through any equally strong structural edge elsewhere. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (ABBV: S&P 500, ROG.SW: STOXX 600).

Updated 2026-05-17

The clearest separation starts in profitability, but valuation adds another real layer to the result. The overall score gap is 38 points in favour of Roche Holding AG.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. ABBV and ROG.SW share the same industry classification.

For a similarity-based comparison, see how AbbVie and Roche each position within their functional peer groups in AssetNext.

Peer-Relative Score
ABBV
AbbVie Inc.
32
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
ROG.SW
Roche Holding AG
70
Peer-Score
Signal qualitylow
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: ABBV vs ROG.SW Profitability 15 86 Stability 68 68 Valuation 15 65 Growth 47 58 ABBV ROG.SW
Gap Ranking
#1 Profitability +71
#2 Valuation +50
#3 Growth +11
#4 Stability
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ABBV and ROG.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ABBVROG.SW Relative valuation Structural strength

Roche Holding AG looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where ABBV and ROG.SW each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY ABBV Elevated · above norm 0th 50th 100th 6 pct gap ROG.SW Elevated · above norm 0th 50th 100th 90th 95th
ABBV (90th percentile) and ROG.SW (95th percentile) both sit in the upper portion of their own 5-year ranges. The historical entry context is broadly similar for both. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Profitability
Roche Holding AG ranks near the top of the group on profitability; AbbVie Inc. sits in the weaker half.
Valuation
The same broad pattern appears on valuation: Roche Holding AG ranks near the top of the group, while AbbVie Inc. stays in the weaker half.
Profitability — Dominant Gap
ABBV
15
ROG.SW
86
Gap+71in favour of ROG.SW

Capital efficiency adds support, with a 21-point ROIC advantage.

What keeps the gap from being one-sided

AbbVie Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both profitability and valuation, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the ABBV vs ROG.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-valuation comparisons

Explore how ABBV and ROG.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.